GlassScriptPhysician profile
Vidya Ramanavarapu
NPI 1477751055
$4,452.01
in general payments reported to CMS, 2019-2025
17 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $768 · 2022: $768 · 2023: $961 · 2024: $737 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Travel and Lodging: $238 · Education: $33.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.56 |
| Travel and Lodging | $238.31 |
| Education | $33.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,278.58 | 2022-2025 | Iovera, Zilretta, Exparel |
| Boston Scientific Corporation | $822.42 | 2019-2025 | Intracept |
| Abbott Laboratories | $469.85 | 2021-2023 | Proclaim |
| Nevro Corp. | $348.48 | 2021-2023 | Senza |
| Medtronic, INC. | $305.76 | 2021-2023 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $198.66 | 2021-2024 | Sprint Pns System |
| Si-Bone, INC. | $180.07 | 2024-2025 | |
| Nalu Medical, INC. | $170.19 | 2025 | Nalu Neurostimulation System |
| Painteq LLC | $156.77 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $135.49 | 2023 | Evoke Scs |
| Curonix LLC | $92.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $86.34 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $75.67 | 2025 | |
| Relievant Medsystems, INC. | $55.57 | 2022 | |
| Stryker Corporation | $37.54 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $20.56 | 2025 | Euflexxa |
| Spinal Simplicity, LLC | $17.35 | 2024 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidya Ramanavarapu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.